NCT05683717 2023-11-21
A Phase 1 Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignancies
TransThera Sciences (Nanjing), Inc.
Phase 1 Recruiting
Clinical Trials
3 trialsNCT05275504 2022-06-09
Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignancies
TransThera Sciences (Nanjing), Inc.
Phase 1 Unknown
NCT01775631 2017-03-31
Combination Study of Urelumab and Rituximab in Patients With B-cell Non-Hodgkins Lymphoma
Bristol-Myers Squibb
Phase 1 Completed